arctigenin has been researched along with Colorectal Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lina, L; Qian, Z; Suoni, L; Wang, Y; Xu, L; Yang, Z; Zhou, J | 1 |
Choi, BM; Han, YH; Hong, SH; Jeong, MY; Kee, JY; Kim, DS; Kim, HJ; Mun, JG; Park, SH; Park, SJ; Um, JY | 1 |
2 other study(ies) available for arctigenin and Colorectal Cancer
Article | Year |
---|---|
Arctigenin enhances the sensitivity of cisplatin resistant colorectal cancer cell by activating autophagy.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Autophagy; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cisplatin; Colorectal Neoplasms; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Furans; Humans; Inhibitory Concentration 50; Lignans; Oxaliplatin; Paclitaxel; Up-Regulation | 2019 |
Arctigenin Inhibits Lung Metastasis of Colorectal Cancer by Regulating Cell Viability and Metastatic Phenotypes.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Female; Furans; Lignans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Metastasis | 2016 |